Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Relative Strength
OCUL
Sector
Showing graph for last 90 days.
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Scholar Rock Holding Corporation | 99 | 2.68% | |
Tevogen Bio Holdings Inc. | 98 | 10.89% | |
Summit Therapeutics Inc. | 98 | 1.96% | |
NewAmsterdam Pharma Company N.V. | 97 | 1.58% | |
Anavex Life Sciences Corp. | 96 | 3.69% |
Forecast
2025-Revenue
2025-EPS
2025-EBITDA
Analyst rating
Price Target
0.00(-100.00%)
Number of analyst
0
Last analyst upgrade/downgrade
Cowen & Co.
upgradePrevious: Hold
2024-06-20
Now: Buy
Earnings Growth
YoY
Current
Estimates
Q4.22
N/A
-0.24
vs -0.23
Q1.23
N/A
-0.31
vs -0.22
Q2.23
N/A
-0.27
vs -0.28
Q3.23
N/A
-0.51
vs -0.30
Q4.23
N/A
-0.28
vs -0.24
Q1.24
N/A
-0.24
vs -0.31
Q2.24
N/A
-0.24
vs -0.27
Q3.24
N/A
-0.26
vs -0.51
Q4.24
N/A
-0.25
vs -0.28
Q1.25
N/A
-0.26
vs -0.24
Sales Growth
YoY
Current
Estimates
Q4.22
+14%
14.1M vs 12.3M
Q1.23
+1%
13.4M vs 13.2M
Q2.23
+24%
15.2M vs 12.3M
Q3.23
+25%
14.9M vs 12M
Q4.23
+5%
14.8M vs 14.1M
Q1.24
+10%
14.7M vs 13.4M
Q2.24
+8%
16.4M vs 15.2M
Q3.24
+3%
15.4M vs 14.9M
Q4.24
+16%
17.2M vs 14.8M
Q1.25
+14%
16.8M vs 14.7M
Return on Equity
QoQ
Q4.22
-33%
-0.33
vs -0.58
Q1.23
-375%
-3.75
vs -0.33
Q2.23
-670%
-6.70
vs -3.75
Q3.23
-7%
-0.07
vs -6.70
Q4.23
-32%
-0.32
vs -0.07
Q1.24
-16%
-0.16
vs -0.32
Q2.24
-12%
-0.12
vs -0.16
Q3.24
-10%
-0.10
vs -0.12
Institutionnal Ownership
QoQ
Q4.22
122
122
vs 136
-10%
Q1.23
133
133
vs 122
9%
Q2.23
143
143
vs 133
8%
Q3.23
119
119
vs 143
-17%
Q4.23
123
123
vs 119
3%
Q1.24
153
153
vs 123
24%
Q2.24
152
152
vs 153
-1%
Q3.24
173
173
vs 152
14%
globenewswire.com
7 hours ago
globenewswire.com
7 hours ago
globenewswire.com
7 hours ago
globenewswire.com
7 hours ago
zacks.com
9 hours ago
seekingalpha.com
12 hours ago